Bradley Foster & Sargent’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $218K | Sell |
3,079
-15
| -0.5% | -$1.12K | ﹤0.01% | 508 |
|
|
2025
Q4 | $244K | Buy |
3,094
+15
| +0.5% | +$1.19K | ﹤0.01% | 493 |
|
|
2025
Q3 | $254K | Hold |
3,079
| – | – | ﹤0.01% | 491 |
|
|
2025
Q2 | $248K | Sell |
3,079
-72
| -2% | -$5.56K | ﹤0.01% | 489 |
|
|
2025
Q1 | $253K | Sell |
3,151
-253
| -7% | -$21K | ﹤0.01% | 426 |
|
|
2024
Q4 | $279K | Hold |
3,404
| – | – | ﹤0.01% | 421 |
|
|
2024
Q3 | $281K | Sell |
3,404
-97
| -3% | -$7.25K | ﹤0.01% | 420 |
|
|
2024
Q2 | $246K | Buy |
3,501
+166
| +5% | +$11.9K | ﹤0.01% | 424 |
|
|
2024
Q1 | $247K | Buy |
3,335
+13
| +0.4% | +$906 | ﹤0.01% | 410 |
|
|
2023
Q4 | $220K | Buy |
+3,322
| New | +$208K | ﹤0.01% | 416 |
|
|
2023
Q1 | – | Sell |
-3,312
| Closed | -$240K | – | 437 |
|
|
2022
Q4 | $240K | Hold |
3,312
| – | – | 0.01% | 394 |
|
|
2022
Q3 | $201K | Hold |
3,312
| – | – | 0.01% | 410 |
|
|
2022
Q2 | $208K | Hold |
3,312
| – | – | 0.01% | 423 |
|
|
2022
Q1 | $233K | Buy |
+3,312
| New | +$224K | 0.01% | 435 |
|
|
2020
Q1 | $314K | Sell |
10,285
-4,101
| -29% | -$182K | 0.01% | 271 |
|
|
2019
Q4 | $733K | Sell |
14,386
-633
| -4% | -$30.6K | 0.02% | 243 |
|
|
2019
Q3 | $708K | Sell |
15,019
-14,660
| -49% | -$699K | 0.02% | 231 |
|
|
2019
Q2 | $1.47M | Sell |
29,679
-4,025
| -12% | -$189K | 0.05% | 184 |
|
|
2019
Q1 | $1.44M | Sell |
33,704
-8,984
| -21% | -$397K | 0.05% | 188 |
|
|
2018
Q4 | $1.75M | Sell |
42,688
-37,720
| -47% | -$1.62M | 0.07% | 165 |
|
|
2018
Q3 | $3.76M | Sell |
80,408
-35,112
| -30% | -$1.6M | 0.13% | 132 |
|
|
2018
Q2 | $5.04M | Sell |
115,520
-23,753
| -17% | -$1.11M | 0.18% | 107 |
|
|
2018
Q1 | $6.39M | Buy |
139,273
+105,643
| +314% | +$5.13M | 0.24% | 89 |
|
|
2017
Q4 | $1.7M | Buy |
33,630
+15,147
| +82% | +$798K | 0.06% | 172 |
|
|
2017
Q3 | $960K | Sell |
18,483
-2,367
| -11% | -$115K | 0.04% | 219 |
|
|
2017
Q2 | $1.02M | Sell |
20,850
-134
| -0.6% | -$6.22K | 0.04% | 205 |
|
|
2017
Q1 | $988K | Hold |
20,984
| – | – | 0.04% | 202 |
|
|
2016
Q4 | $1.01M | Buy |
20,984
+134
| +0.6% | +$6.15K | 0.04% | 201 |
|
|
2016
Q3 | $826K | Buy |
20,850
+12,524
| +150% | +$471K | 0.04% | 210 |
|
|
2016
Q2 | $296K | Sell |
8,326
-2,271
| -21% | -$88.6K | 0.01% | 289 |
|
|
2016
Q1 | $415K | Sell |
10,597
-3,815
| -26% | -$143K | 0.02% | 255 |
|
|
2015
Q4 | $619K | Sell |
14,412
-1,795
| -11% | -$78.9K | 0.03% | 221 |
|
|
2015
Q3 | $681K | Sell |
16,207
-916
| -5% | -$42.8K | 0.03% | 218 |
|
|
2015
Q2 | $854K | Buy |
17,123
+1,083
| +7% | +$51.3K | 0.04% | 210 |
|
|
2015
Q1 | $723K | Sell |
16,040
-628
| -4% | -$28.2K | 0.03% | 230 |
|
|
2014
Q4 | $804K | Buy |
16,668
+291
| +2% | +$13.8K | 0.04% | 211 |
|
|
2014
Q3 | $784K | Buy |
16,377
+561
| +4% | +$27.2K | 0.04% | 217 |
|
|
2014
Q2 | $783K | Sell |
15,816
-757
| -5% | -$35.4K | 0.04% | 211 |
|
|
2014
Q1 | $780K | Sell |
16,573
-5,861
| -26% | -$269K | 0.04% | 208 |
|
|
2013
Q4 | $1.08M | Buy |
22,434
+161
| +0.7% | +$7.22K | 0.06% | 190 |
|
|
2013
Q3 | $932K | Hold |
22,273
| – | – | 0.05% | 182 |
|
|
2013
Q2 | $908K | Buy |
+22,273
| New | +$819K | 0.06% | 176 |
|
Other funds holding MET
VCM
VPM
Bradley Foster & Sargent's MET Position: Q1 2026 in Review
Bradley Foster & Sargent reduced its MetLife (MET) stake by 0.48% in Q1 2026, selling an estimated $1.12K and leaving 3,079 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #508.
Bradley Foster & Sargent first reported a position in MET in Q2 2013 and has held it in 42 quarters since. The position peaked at $6.39M in Q1 2018. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Bradley Foster & Sargent held 3,079 shares of MetLife worth $218K as of Q1 2026.
- Bradley Foster & Sargent sold 15 MetLife shares in Q1 2026, an estimated $1.12K.
- MetLife made up ﹤0.01% of Bradley Foster & Sargent's portfolio in Q1 2026, its #508 holding.
- Bradley Foster & Sargent first reported a position in MetLife in Q2 2013 and has held it in 42 quarters since.
- Bradley Foster & Sargent's MetLife position peaked at $6.39M in Q1 2018.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Bradley Foster & Sargent's 13F filing for Q1 2026, filed 15 May 2026.